Ingevity Corporation (NGVT) Dividend History

Company News

• Ingevity's (NGVT) Earnings and Revenues Miss Estimates in Q2

  Ingevity Corporation reported a Q2 2024 loss of $283.7 million or $7.81 per share, down from a profit of $35.5 million a year ago. Revenues declined 18.9% year-over-year to $390.6 million, missing estimates. The company revised its sales and adjusted EBITDA guidance for 2024.

  Zacks Investment Research

  Featured Companies: HL
• Assessing Ingevity: Insights From 5 Financial Analysts - Benzinga

  The article analyzes the recent ratings and price targets of 5 financial analysts for Ingevity, a chemical manufacturer. The analysts have a mixed outlook, with an average 12-month price target of $55.2 and a range of ratings from 'Outperform' to 'Underperform'. The company's financial performance, including declining revenue, low profitability, and high debt levels, are also discussed.

  Benzinga
• Ingevity (NGVT), Ultrapolymers Tie-Up for Capa Bioplastics Sales - Zacks Investment Research

  Ingevity Corporation has expanded its Capa caprolactone distribution network by selecting Ultrapolymers Group as the distributor for Capa Bioplastics in Europe. This move aligns with Ingevity's growth strategy in the region.

  Zacks Investment Research
• Ingevity finalizes termination of key supply agreement By Investing.com - Investing.com

  Ingevity Corp has finalized the termination of a significant crude tall oil supply agreement with GP Pine Chemicals, a subsidiary of Georgia-Pacific. The termination provides Ingevity more flexibility as it plans to restructure its Performance Chemicals business segment to focus on specialty chemicals markets.

  Investing.com
• Ingevity (NGVT) Down 12.4% Since Last Earnings Report: Can It Rebound?

  Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  Zacks Investment Research

  Featured Companies: ECL